These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34967094)

  • 21. Coronary Artery Healing Process after Bioresorbable Scaffold in Patients with Non-ST-Segment Elevation Myocardial Infarction: Rationale, Design, and Methodology of the HONEST Study.
    Fallesen CO; Maehara A; Antonsen L; Nørregaard Hansen K; Noori M; Flensted Lassen J; Junker A; Hansen HS; Okkels Jensen L
    Cardiology; 2021; 146(2):161-171. PubMed ID: 33524985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary Report of Clinical Outcomes After Single Crossover Bioresorbable Scaffold Implantation Without Routine Side Branch Strut Dilation.
    Tanaka A; Jabbour RJ; Kawamoto H; Mangieri A; Pagnesi M; Montalto C; Chieffo A; Carlino M; Montorfano M; Latib A; Colombo A
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):865-870. PubMed ID: 27219102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold versus everolimus-eluting stent for coronary bifurcation lesions.
    Naganuma T; Kawamoto H; Panoulas VF; Latib A; Tanaka A; Mitomo S; Ruparelia N; Jabbour RJ; Chieffo A; Carlino M; Montorfano M; Colombo A
    Int J Cardiol; 2017 Nov; 246():26-31. PubMed ID: 28867010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiographic and Midterm Outcomes of Bioresorbable Vascular Scaffold for Coronary Bifurcation Lesions.
    Paradies V; Vlachojannis GJ; Royaards KJ; Wassing J; van der Ent M; Smits PC
    Am J Cardiol; 2018 Dec; 122(12):2035-2042. PubMed ID: 30360886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.
    Serruys PW; Onuma Y; Ormiston JA; de Bruyne B; Regar E; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Miquel-Hebert K; Rapoza R; García-García HM
    Circulation; 2010 Nov; 122(22):2301-12. PubMed ID: 21098436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implantation of bioresorbable scaffolds under guidance of optical coherence tomography: Feasibility and pilot clinical results of a systematic protocol.
    Gutiérrez-Chico JL; Cortés C; Schincariol M; Limon U; Yalcinli M; Durán-Cortés MA; Jaguszewski M
    Cardiol J; 2018; 25(4):443-458. PubMed ID: 29774520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequential Proximal Optimizing Technique in Provisional Bifurcation Stenting With Everolimus-Eluting Bioresorbable Vascular Scaffold: Fractal Coronary Bifurcation Bench for Comparative Test Between Absorb and XIENCE Xpedition.
    Derimay F; Souteyrand G; Motreff P; Guerin P; Pilet P; Ohayon J; Darremont O; Rioufol G; Finet G
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1397-406. PubMed ID: 27388830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro mechanical behavior and in vivo healing response of a novel thin-strut ultrahigh molecular weight poly-l-lactic acid sirolimus-eluting bioresorbable coronary scaffold in normal swine.
    Cheng Y; Gasior P; Ramzipoor K; Lee C; McGregor JC; Conditt GB; McAndrew T; Kaluza GL; Granada JF
    Int J Cardiol; 2019 Jul; 286():21-28. PubMed ID: 30967275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized Comparison of Absorb Bioresorbable Vascular Scaffold and Mirage Microfiber Sirolimus-Eluting Scaffold Using Multimodality Imaging.
    Tenekecioglu E; Serruys PW; Onuma Y; Costa R; Chamié D; Sotomi Y; Yu TB; Abizaid A; Liew HB; Santoso T
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1115-1130. PubMed ID: 28527768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioresorbable Scaffolds for the Management of Coronary Bifurcation Lesions.
    Kawamoto H; Ruparelia N; Tanaka A; Chieffo A; Latib A; Colombo A
    JACC Cardiovasc Interv; 2016 May; 9(10):989-1000. PubMed ID: 27198679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fate of post-procedural malapposition of everolimus-eluting polymeric bioresorbable scaffold and everolimus-eluting cobalt chromium metallic stent in human coronary arteries: sequential assessment with optical coherence tomography in ABSORB Japan trial.
    Sotomi Y; Onuma Y; Dijkstra J; Miyazaki Y; Kozuma K; Tanabe K; Popma JJ; de Winter RJ; Serruys PW; Kimura T
    Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):59-66. PubMed ID: 28158421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnesium versus poly-L-lactic acid bioresorbable scaffolds: in vivo optical coherence tomography comparison of mechanical performance.
    Abellás-Sequeiros RA; Ocaranza-Sanchez R; Galvaõ-Braga C; Marques J; Gonzalez-Juanatey C
    Arch Cardiol Mex; 2020; 90(1):8-15. PubMed ID: 31996867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary Lesions.
    Abizaid A; Costa RA; Schofer J; Ormiston J; Maeng M; Witzenbichler B; Botelho RV; Costa JR; Chamié D; Abizaid AS; Castro JP; Morrison L; Toyloy S; Bhat V; Yan J; Verheye S
    JACC Cardiovasc Interv; 2016 Mar; 9(6):565-74. PubMed ID: 27013155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Relation Between Optical Coherence Tomography-Detected Layered Pattern and Acute Side Branch Occlusion after Provisional Stenting of Coronary Bifurcation Lesions.
    Cao Y; Mintz GS; Matsumura M; Zhang W; Lin Y; Wang X; Fujino A; Lee T; Murai T; Hoshino M; Usui E; Kanaji Y; Yonetsu T; Kakuta T; Maehara A
    Cardiovasc Revasc Med; 2019 Nov; 20(11):1007-1013. PubMed ID: 30683562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plaque morphology predictors of side branch occlusion after provisional stenting in coronary bifurcation lesion: Results of optical coherence tomography bifurcation study (ORBID).
    Kini AS; Vengrenyuk Y; Pena J; Yoshimura T; Panwar SR; Motoyama S; Kezbor S; Hasan CM; Palkhiwala S; Kovacic JC; Moreno P; Baber U; Mehran R; Narula J; Sharma SK
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):259-268. PubMed ID: 27029714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usability of Fantom Encore® scaffold in non-complex bifurcations-Analysis in bench models.
    G Toth G; Ono M; Buschmann E; Wu X; Edl D; Onuma Y; Serruys PW; Wijns W
    Catheter Cardiovasc Interv; 2022 Feb; 99(2):424-432. PubMed ID: 33565719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of coronary bifurcation lesions with the Absorb bioresorbable vascular scaffold in combination with the Tryton dedicated coronary bifurcation stent: evaluation using two- and three-dimensional optical coherence tomography.
    Grundeken MJ; Hassell ME; Kraak RP; de Bruin DM; Koch KT; Henriques JP; van Leeuwen TG; Tijssen JG; Piek JJ; de Winter RJ; Wykrzykowska JJ
    EuroIntervention; 2015 Dec; 11(8):877-84. PubMed ID: 25169592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The absorb bioresorbable vascular scaffold in coronary bifurcations: insights from bench testing.
    Džavík V; Colombo A
    JACC Cardiovasc Interv; 2014 Jan; 7(1):81-8. PubMed ID: 24332424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioresorbable vascular scaffolds in coronary chronic total occlusions revascularization: safety assessment related to struts coverage and apposition in 6-month OCT follow-up.
    Abellas-Sequeiros RA; Ocaranza-Sanchez R; Trillo-Nouche R; Gonzalez-Juanatey C; Gonzalez-Juanatey JR
    Heart Vessels; 2017 Sep; 32(9):1077-1084. PubMed ID: 28432385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.